Perceptive Advisors - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$21,093,800
-55.2%
617,500
-49.5%
0.70%
-48.3%
Q2 2023$47,100,015
-28.2%
1,223,377
-33.2%
1.36%
-29.6%
Q1 2023$65,573,507
-13.4%
1,832,174
-4.6%
1.94%
-9.0%
Q4 2022$75,755,794
-1.1%
1,921,273
-9.5%
2.13%
-4.4%
Q3 2022$76,624,000
+18.7%
2,122,5350.0%2.22%
+10.0%
Q2 2022$64,568,000
-12.4%
2,122,535
-12.0%
2.02%
+36.9%
Q1 2022$73,718,000
-51.1%
2,411,447
-50.0%
1.48%
+27.1%
Q4 2021$150,668,000
+387.6%
4,822,894
+138.5%
1.16%
+158.8%
Q3 2021$30,897,000
-50.6%
2,022,051
-39.8%
0.45%
+10.6%
Q2 2021$62,524,000
+578.2%
3,357,946
+552.0%
0.41%
+247.0%
Q1 2021$9,219,000
+304.3%
515,042
-28.8%
0.12%
+1.7%
Q2 2017$2,280,000
-21.2%
723,8530.0%0.12%
-30.3%
Q1 2017$2,895,000
-49.2%
723,853
-2.2%
0.16%
-59.3%
Q4 2016$5,700,000
-7.8%
740,272
-3.0%
0.40%
+1.5%
Q3 2016$6,179,000
+142.0%
762,800
+76.2%
0.40%
+125.4%
Q2 2016$2,553,000
+77.5%
432,800
+110.3%
0.18%
+40.5%
Q1 2016$1,438,000
-13.1%
205,8000.0%0.13%
+3.3%
Q4 2015$1,655,000
-51.3%
205,800
-50.0%
0.12%
-10.3%
Q3 2015$3,398,000
+31.0%
411,600
+82.9%
0.14%
-12.8%
Q2 2015$2,594,000
-31.6%
225,0000.0%0.16%
-47.1%
Q1 2015$3,795,000
-14.6%
225,0000.0%0.30%
-20.9%
Q4 2014$4,444,000225,0000.37%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders